The special pathogens research network: Enabling research readiness

Colleen S. Kraft, Mark G. Kortepeter, Bruce Gordon, Lauren M. Sauer, Erica S. Shenoy, Daniel P. Eiras, Lu Ann Larson, Jennifer A. Garland, Aneesh K. Mehta, Kevin Barrett, Connie S. Price, Caroline Croyle, Lauren R. West, Brooke Noren, Susan Kline, Christa Arguinchona, Henry Arguinchona, Jonathan D. Grein, Chad Connally, Susan McLellanGeorge F. Risi, Timothy M. Uyeki, Richard T. Davey, Jo Ellen Schweinle, Michelle M. Schwedhelm, Melissa Harvey, Richard C. Hunt, Christopher J. Kratochvil

Research output: Contribution to journalArticle

Abstract

The 2013-2016 epidemic of Ebola virus disease (EVD) that originated in West Africa underscored many of the challenges to conducting clinical research during an ongoing infectious disease epidemic, both in the most affected countries of Guinea, Liberia, and Sierra Leone, as well as in the United States and Europe, where a total of 27 patients with EVD received care in biocontainment units. The Special Pathogens Research Network (SPRN) was established in the United States in November 2016 to provide an organizational structure to leverage the expertise of the 10 Regional Ebola and Other Special Pathogen Treatment Centers (RESPTCs); it was intended to develop and support infrastructure to improve readiness to conduct clinical research in the United States. The network enables the rapid activation and coordination of clinical research in the event of an epidemic and facilitates opportunities for multicenter research when the RESPTCs are actively caring for patients requiring a biocontainment unit. Here we provide an overview of opportunities identified in the clinical research infrastructure during the West Africa EVD epidemic and the SPRN activities to meet the ongoing challenges in the context of Ebola virus and other special pathogens.

Original languageEnglish (US)
Pages (from-to)35-45
Number of pages11
JournalHealth Security
Volume17
Issue number1
DOIs
StatePublished - Jan 1 2019

Fingerprint

Pathogens
pathogen
Ebola Hemorrhagic Fever
Viruses
Research
Western Africa
West Africa
Disease
Liberia
Sierra Leone
infrastructure
Ebolavirus
Guinea
infectious disease
organizational structure
activation
contagious disease
Communicable Diseases
expertise
Chemical activation

Keywords

  • Clinical research
  • Ebola virus disease
  • Investigational therapeutics
  • Special pathogens

ASJC Scopus subject areas

  • Health(social science)
  • Emergency Medicine
  • Safety Research
  • Public Health, Environmental and Occupational Health
  • Management, Monitoring, Policy and Law
  • Health, Toxicology and Mutagenesis

Cite this

The special pathogens research network : Enabling research readiness. / Kraft, Colleen S.; Kortepeter, Mark G.; Gordon, Bruce; Sauer, Lauren M.; Shenoy, Erica S.; Eiras, Daniel P.; Larson, Lu Ann; Garland, Jennifer A.; Mehta, Aneesh K.; Barrett, Kevin; Price, Connie S.; Croyle, Caroline; West, Lauren R.; Noren, Brooke; Kline, Susan; Arguinchona, Christa; Arguinchona, Henry; Grein, Jonathan D.; Connally, Chad; McLellan, Susan; Risi, George F.; Uyeki, Timothy M.; Davey, Richard T.; Schweinle, Jo Ellen; Schwedhelm, Michelle M.; Harvey, Melissa; Hunt, Richard C.; Kratochvil, Christopher J.

In: Health Security, Vol. 17, No. 1, 01.01.2019, p. 35-45.

Research output: Contribution to journalArticle

Kraft, CS, Kortepeter, MG, Gordon, B, Sauer, LM, Shenoy, ES, Eiras, DP, Larson, LA, Garland, JA, Mehta, AK, Barrett, K, Price, CS, Croyle, C, West, LR, Noren, B, Kline, S, Arguinchona, C, Arguinchona, H, Grein, JD, Connally, C, McLellan, S, Risi, GF, Uyeki, TM, Davey, RT, Schweinle, JE, Schwedhelm, MM, Harvey, M, Hunt, RC & Kratochvil, CJ 2019, 'The special pathogens research network: Enabling research readiness', Health Security, vol. 17, no. 1, pp. 35-45. https://doi.org/10.1089/hs.2018.0106
Kraft, Colleen S. ; Kortepeter, Mark G. ; Gordon, Bruce ; Sauer, Lauren M. ; Shenoy, Erica S. ; Eiras, Daniel P. ; Larson, Lu Ann ; Garland, Jennifer A. ; Mehta, Aneesh K. ; Barrett, Kevin ; Price, Connie S. ; Croyle, Caroline ; West, Lauren R. ; Noren, Brooke ; Kline, Susan ; Arguinchona, Christa ; Arguinchona, Henry ; Grein, Jonathan D. ; Connally, Chad ; McLellan, Susan ; Risi, George F. ; Uyeki, Timothy M. ; Davey, Richard T. ; Schweinle, Jo Ellen ; Schwedhelm, Michelle M. ; Harvey, Melissa ; Hunt, Richard C. ; Kratochvil, Christopher J. / The special pathogens research network : Enabling research readiness. In: Health Security. 2019 ; Vol. 17, No. 1. pp. 35-45.
@article{a80c02fee9ac488ea64e2873be614488,
title = "The special pathogens research network: Enabling research readiness",
abstract = "The 2013-2016 epidemic of Ebola virus disease (EVD) that originated in West Africa underscored many of the challenges to conducting clinical research during an ongoing infectious disease epidemic, both in the most affected countries of Guinea, Liberia, and Sierra Leone, as well as in the United States and Europe, where a total of 27 patients with EVD received care in biocontainment units. The Special Pathogens Research Network (SPRN) was established in the United States in November 2016 to provide an organizational structure to leverage the expertise of the 10 Regional Ebola and Other Special Pathogen Treatment Centers (RESPTCs); it was intended to develop and support infrastructure to improve readiness to conduct clinical research in the United States. The network enables the rapid activation and coordination of clinical research in the event of an epidemic and facilitates opportunities for multicenter research when the RESPTCs are actively caring for patients requiring a biocontainment unit. Here we provide an overview of opportunities identified in the clinical research infrastructure during the West Africa EVD epidemic and the SPRN activities to meet the ongoing challenges in the context of Ebola virus and other special pathogens.",
keywords = "Clinical research, Ebola virus disease, Investigational therapeutics, Special pathogens",
author = "Kraft, {Colleen S.} and Kortepeter, {Mark G.} and Bruce Gordon and Sauer, {Lauren M.} and Shenoy, {Erica S.} and Eiras, {Daniel P.} and Larson, {Lu Ann} and Garland, {Jennifer A.} and Mehta, {Aneesh K.} and Kevin Barrett and Price, {Connie S.} and Caroline Croyle and West, {Lauren R.} and Brooke Noren and Susan Kline and Christa Arguinchona and Henry Arguinchona and Grein, {Jonathan D.} and Chad Connally and Susan McLellan and Risi, {George F.} and Uyeki, {Timothy M.} and Davey, {Richard T.} and Schweinle, {Jo Ellen} and Schwedhelm, {Michelle M.} and Melissa Harvey and Hunt, {Richard C.} and Kratochvil, {Christopher J.}",
year = "2019",
month = "1",
day = "1",
doi = "10.1089/hs.2018.0106",
language = "English (US)",
volume = "17",
pages = "35--45",
journal = "Health security",
issn = "2326-5094",
publisher = "Mary Ann Liebert Inc.",
number = "1",

}

TY - JOUR

T1 - The special pathogens research network

T2 - Enabling research readiness

AU - Kraft, Colleen S.

AU - Kortepeter, Mark G.

AU - Gordon, Bruce

AU - Sauer, Lauren M.

AU - Shenoy, Erica S.

AU - Eiras, Daniel P.

AU - Larson, Lu Ann

AU - Garland, Jennifer A.

AU - Mehta, Aneesh K.

AU - Barrett, Kevin

AU - Price, Connie S.

AU - Croyle, Caroline

AU - West, Lauren R.

AU - Noren, Brooke

AU - Kline, Susan

AU - Arguinchona, Christa

AU - Arguinchona, Henry

AU - Grein, Jonathan D.

AU - Connally, Chad

AU - McLellan, Susan

AU - Risi, George F.

AU - Uyeki, Timothy M.

AU - Davey, Richard T.

AU - Schweinle, Jo Ellen

AU - Schwedhelm, Michelle M.

AU - Harvey, Melissa

AU - Hunt, Richard C.

AU - Kratochvil, Christopher J.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - The 2013-2016 epidemic of Ebola virus disease (EVD) that originated in West Africa underscored many of the challenges to conducting clinical research during an ongoing infectious disease epidemic, both in the most affected countries of Guinea, Liberia, and Sierra Leone, as well as in the United States and Europe, where a total of 27 patients with EVD received care in biocontainment units. The Special Pathogens Research Network (SPRN) was established in the United States in November 2016 to provide an organizational structure to leverage the expertise of the 10 Regional Ebola and Other Special Pathogen Treatment Centers (RESPTCs); it was intended to develop and support infrastructure to improve readiness to conduct clinical research in the United States. The network enables the rapid activation and coordination of clinical research in the event of an epidemic and facilitates opportunities for multicenter research when the RESPTCs are actively caring for patients requiring a biocontainment unit. Here we provide an overview of opportunities identified in the clinical research infrastructure during the West Africa EVD epidemic and the SPRN activities to meet the ongoing challenges in the context of Ebola virus and other special pathogens.

AB - The 2013-2016 epidemic of Ebola virus disease (EVD) that originated in West Africa underscored many of the challenges to conducting clinical research during an ongoing infectious disease epidemic, both in the most affected countries of Guinea, Liberia, and Sierra Leone, as well as in the United States and Europe, where a total of 27 patients with EVD received care in biocontainment units. The Special Pathogens Research Network (SPRN) was established in the United States in November 2016 to provide an organizational structure to leverage the expertise of the 10 Regional Ebola and Other Special Pathogen Treatment Centers (RESPTCs); it was intended to develop and support infrastructure to improve readiness to conduct clinical research in the United States. The network enables the rapid activation and coordination of clinical research in the event of an epidemic and facilitates opportunities for multicenter research when the RESPTCs are actively caring for patients requiring a biocontainment unit. Here we provide an overview of opportunities identified in the clinical research infrastructure during the West Africa EVD epidemic and the SPRN activities to meet the ongoing challenges in the context of Ebola virus and other special pathogens.

KW - Clinical research

KW - Ebola virus disease

KW - Investigational therapeutics

KW - Special pathogens

UR - http://www.scopus.com/inward/record.url?scp=85061820678&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85061820678&partnerID=8YFLogxK

U2 - 10.1089/hs.2018.0106

DO - 10.1089/hs.2018.0106

M3 - Article

C2 - 30779607

AN - SCOPUS:85061820678

VL - 17

SP - 35

EP - 45

JO - Health security

JF - Health security

SN - 2326-5094

IS - 1

ER -